J. Stephen Fink, MD, PhD (1950-2002).

Abstract

Our friend, our colleague, and a pioneer of research on the adenosine A2A receptor in the service of improved neurotherapeutics, Dr. J. Stephen Fink, died December 30, 2002 (figure). Steve originally accepted an invitation to chair a session at this symposium but later reluctantly informed us he would be unable to participate because of the recently diagnosed glioblastoma that would claim his life only 3 months later. His death deeply saddens us and is a painful loss to the adenosine receptor and Parkinson’s disease (PD) research communities. Steve was a gifted scientist who seamlessly combined his basic and clinical research skills to advance our knowledge of the A2A receptor and PD. J. Stephen Fink, MD, PhD (1950–2002) Steve trained as a movement disorder specialist at Massachusetts General …